Rhumbline Advisers Mirum Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 64,593 shares of MIRM stock, worth $4.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,593
Previous 55,434
16.52%
Holding current value
$4.63 Million
Previous $2.5 Million
31.64%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$488 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$376 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$232 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$198 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$189 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...